Further Information
Endogenous retrovirus group 3 member 1 Env polyprotein, ERV-3 envelope protein, ERV3 envelope protein, ERV3-1 envelope protein, Envelope polyprotein, HERV-R envelope protein, ERV-R envelope protein, HERV-R_7q212 provirus ancestral Env polyprotein, Surface protein, SU, Transmembrane protein, TM, ERV3-1, ERV3
For WB starting dilution is: 1:1000
For IHC-P starting dilution is: 1:10~50
The human genome includes many retroelements including the
human endogenous retroviruses (HERVs). ERV3, one of the most
studied HERVs, is thought to have integrated 30 to 40 million years
ago and is present in higher primates with the exception of
gorillas. Taken together, the observation of genome conservation,
the detection of transcript expression, and the presence of
conserved ORFs is circumstantial evidence for a functional role. A
functional role is also suggested by the observation that
downregulation of ERV3 is reported in choriocarcinoma. [provided by
RefSeq].
- Andersson, A.C., et al. J. Virol. 79(14):9270-9284(2005)
- Herve, C.A., et al. Genomics 83(5):940-943(2004)
- Blaise, S., et al. Proc. Natl. Acad. Sci. U.S.A. 100(22):13013-13018(2003)
- de Parseval, N., et al. J. Virol. 77(19):10414-10422(2003)
Supplied in PBS with 0.09% (W/V) sodium azide.
batch dependent
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
This ERV3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 445-474 amino acids from the C-terminal region of human ERV3.
2086
Endogenous retrovirus group 3 member 1 Env polyprotein
ERV3-1
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
68 kDa
Q14264
44887883
This antibody is purified through a protein A column, followed by peptide affinity purification.
Cell Cycle,
Q14264
Optimal dilutions for each application to be determined by the researcher.